MedChemComm p. 2122 - 2127 (2016)
Update date:2022-08-04
Topics:
Phummarin, Narisa
Boshoff, Helena I.
Tsang, Patricia S.
Dalton, James
Wiles, Siouxsie
Barry, Clifton E.
Copp, Brent R.
A previous phenotypic screen by GSK identified 2-(quinolin-4-yloxy)acetamides as potent growth inhibitors of Mycobacterium tuberculosis (Mtb). We report the results of a preliminary structure-activity relationship (SAR) study of the compound class which has yielded more potent inhibitors. An Mtb cytochrome bd oxidase deletion mutant (cydKO) was found to be hypersensitive to most members of the compound library, while strains carrying single-nucleotide polymorphisms of the qcrB gene, which encodes a subunit of the menaquinol cytochrome c oxidoreductase (bc1) complex, were resistant to the library. These results identify that the 2-(quinolin-4-yloxy)acetamide class of Mtb growth inhibitors can be added to the growing number of scaffolds that target the M. tuberculosis bc1 complex.
View MoreTianjin Jingye Fine Chemicals Co., Ltd.
Contact:+86-15722078107; +86-22-26911407
Address:Bohua Fine Chemicals Base of Petrochemical Industry Park, Nanhuan Road, Dagang District, Tianjin, 300271, P. R. China
Shanghai Yuanye Bio-Technology Co., Ltd.
website:http://www.shyuanye.com
Contact:+86-21-61845781
Address:Building 6, No. 465, Changta Road,Songjiang District,Shanghai,China
Contact:+86-731-84427351
Address:154 JIANXIANG SOUTH ROAD
Henan Techway Chemical Co.,Ltd.
website:http://www.techwaychem.com
Contact:+86-371-66380080
Address:No.27 Shunhe Road,
Melone Pharmaceutical Co., ltd
Contact:+86-411 82593920, 82593631
Address:No 232, JInma Roda, Development Zone, Dalian, China
Doi:10.1039/DT9770001292
()Doi:10.1021/acsmedchemlett.9b00661
(2020)Doi:10.1021/acs.orglett.9b03119
(2019)Doi:10.1016/0040-4039(91)80655-P
(1991)Doi:10.1021/ja0385639
(2003)Doi:10.1055/a-1337-6459
(2021)